Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of different anesthesia protocols on microelectrode recording during DBS
ChiCTR2400086825Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and propofol in Parkinson's disease (PD) (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: Root mean square values of local field potential, Power spectrum density and 3 more. Started Jul 2024; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ChiCTR2400086825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086825.